Cardiff Oncology Inc. buy secretariat
Start price
19.09.20
/
50%
€7.40
Target price
23.09.20
-
Performance (%)
34.46%
End price
23.09.20
€9.95
Summary
This prediction ended on 23.09.20 with a price of €9.95. The BUY prediction by secretariat for Cardiff Oncology Inc. saw massive gains of 34.46%. secretariat has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | 2.205% | 2.205% | -58.899% | -10.160% |
| iShares Core DAX® | 0.271% | 2.504% | 3.327% | 50.436% |
| iShares Nasdaq 100 | 1.884% | 3.490% | 35.658% | 88.226% |
| iShares Nikkei 225® | 3.579% | 8.127% | 56.653% | 65.166% |
| iShares S&P 500 | 0.151% | 1.918% | 24.108% | 64.489% |
According to secretariat what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by secretariat for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.